334 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
to a resolution approved by a
Exhibit 3.1
majority of the entire Board of Directors, or (iii) by the Secretary of the corporation, following his or her receipt … , the purpose or purposes for which the meeting is called.
Section 10. Quorum and Adjournments.
(a) The holders of a majority of the stock issued
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
transactions, of (a) a majority of the Voting Stock or other controlling ownership interest in another Person (including the purchase of an option … that such “person” or “group” has the right to acquire pursuant to any option right); or
(b) during any period of twelve (12) consecutive months, a majority
S-3ASR
xr40v2
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-4.3
waln2e7s7h
30 Sep 22
Automatic shelf registration
4:17pm
425
EX-99.1
glpoh
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
q9xh8p t1qih8oan
21 Jun 22
Regulation FD Disclosure
6:19am
S-8
EX-10.2
icyjzob bhu
13 Jun 22
Registration of securities for employees
8:44am
425
48gzwc h9fiyrwhyp0
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
p5fqisomnznr i3rjcf
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
p8jnidl21rxr2l
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
DEFA14A
43rzlq16e4o542o8ja
18 May 21
Additional proxy soliciting materials
5:00pm